Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Verapamil"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringVerapamil
brandStringCalan, Calan SR, Verelan, Verelan PM, Isoptin SR
structureFile
classesList of String, delimiter: ,[[:Category:Calcium_channel_blockers|Calcium channel blocker (non-dihydropyridine)]] [[:Category:Antianginals|Antianginal]] [[:Category:Antiarrhythmics|Antiarrhythmic (class IV)]] [[:Category:Antihypertensives|Antihypertensive]]
mechanismString
usesString'"`UNIQ--vote-00000A66-QINU`"', '"`UNIQ--vote-00000A67-QINU`"', '"`UNIQ--vote-00000A68-QINU`"', '"`UNIQ--vote-00000A69-QINU`"', '"`UNIQ--vote-00000A6A-QINU`"'
starting_doseStringIR 80-120 mg PO TID; ER 180-240 mg PO daily; IV 2.5-5 mg over 2 min for SVT termination (under monitoring); cluster prophylaxis up to 480-960 mg/d in divided doses
preparationsStringIR 40, 80, 120 mg tablets; SR/ER 100-360 mg; IV 2.5 mg/mL
fda_maxString~480 mg/d (oral) for cardiovascular indications; higher off-label for cluster
pill_idText
routesList of String, delimiter: ,Oral (IR and multiple ER) IV
onsetStringIV: 1-3 minutes (SVT termination); PO IR: 30-60 minutes; ER: hours
durationStringIR: 6-8 hours; ER: 24 hours
halflifeString3-7 hours (IR); functional 24 hours (ER)'"`UNIQ--ref-00000A6B-QINU`"'
bioavailabilityString~20-35% (oral; extensive first-pass via CYP3A4 with R/S enantiomer differences)'"`UNIQ--ref-00000A6C-QINU`"'
pregnancyStringLimited data; alternative antihypertensives generally preferred. Crosses placenta.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US